Related Experiment Video
Updated: Jan 7, 2026

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy
Published on: December 30, 2025
MXenes in diabetes: diagnostic and therapeutic applications
Meisam Samadzadeh1, Mahshid Danesh2, Atefeh Zarepour3
1Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Istinye University Istanbul 34396 Türkiye.
Abstract:
This review highlights the promising role of MXenes and their composites in diabetes management, emphasizing their dual utility in diagnostics and therapeutics. MXenes' exceptional electrical conductivity, hydrophilicity, mechanical robustness, and tunable surface chemistry facilitate the design of sensitive and selective biosensors for real-time and non-invasive monitoring of key diabetes biomarkers like glucose and acetone. Therapeutically, MXene-based materials enhance healing of diabetic complications such as foot ulcers by modulating inflammation, scavenging reactive oxygen species, promoting angiogenesis, and supporting tissue regeneration via multifunctional hydrogels, patches, and scaffolds. Despite these advances, challenges remain including environmentally harmful synthesis methods, limited scalability, oxidation-induced instability under physiological conditions, and insufficient biocompatibility data. Future efforts are directed toward developing greener and scalable synthesis routes, improving MXene stability through surface modifications, and integrating MXenes with cutting-edge technologies such as wearable devices, 3D bioprinting, and bioelectronics. Additionally, the review uniquely explores the incorporation of artificial intelligence and machine learning techniques to enable personalized and adaptive diabetes management. By providing a comprehensive synthesis of recent developments, current limitations, and innovative future directions, this review offers novel insights aimed at accelerating the clinical translation of MXene-based platforms to significantly enhance diabetes diagnosis and treatment.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

